Two new prescription weight loss drugs, Belviq and Qsymia, now have the FDA's blessing. Which, if either, is for you?

What is Qsymia? Qsymia is a combination of the appetite suppressant phentermine (the safe half of the diet drug Fen-Phen) and the anti-seizure/migraine medication topiramate. It is manufactured by ...

Vivus, Inc. announced that Qsymia (phentermine and topiramate extended-release) capsules are now available. Qsymia (formerly known as Qnexa) is indicated as an adjunct to a reduced-calorie diet ...

Investing.com -- GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral weight management drug Qsymia for $149.

Qysmia capsules, previously available only through a certified mail-order pharmacy network, are now available in more than 8,000 retail pharmacies.

QSYMIA is the leading non-injectable branded weight loss medication in the U.S. for adults. QSYMIA is a combination of phentermine, a sympathomimetic amine anorectic, and topiramate, indicated in ...

On Tuesday, the Food and Drug Administration (FDA) approved Qsymia, the second new diet drug in a month, and the most effective of the weight-loss pills that the agency has considered in recent ...

Starting today, the newly FDA-approved diet drug Qsymia is available by prescription. Made by Vivus Inc., the weight-loss pill is approved for obese patients with a body mass index (BMI) of 30 or ...

The U.S. Food and Drug Administration approved the new weight loss pill Qsymia on Tuesday, adding to a very skimpy arsenal of drugs Americans can take to battle severe obesity -- and adding a last ...

Qsymia, the combination diet drug composed of phentermine and topiramate, was approved by the FDA in July of 2012. Now, the results of a study conducted between December 2007 and September 2008 and ...

The U.S. Food and Drug Administration approved the new weight loss pill Qsymia on Tuesday, adding to a very skimpy arsenal of drugs Americans can take to battle severe obesity -- amd adding a last ...